The Evaluation of Serum Biomarkers for Non-small Cell Lung Cancer (NSCLC) Diagnosis

The Evaluation of Serum Biomarkers for Non-small Cell Lung Cancer (NSCLC) Diagnosis

Introduction: Lung cancer ranks top in the cause of cancer death globally. The identification of effective biomarkers is essential for non-small cell lung cancer (NSCLC) diagnosis.Methods: The expression levels of prolactin (PRL), CEA, and CYFR21 in serum were assayed by ELISA. The blood samples wer...

Full description

Bibliographic Details
Main Authors: Rui Fang, Yong Zhu, Vedbar S. Khadka, Fan Zhang, Bin Jiang, Youping Deng
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-11-01
Series:Frontiers in Physiology
Subjects:
lung cancer
NSCLC
serum
biomarkers
diagnosis
Online Access:https://www.frontiersin.org/article/10.3389/fphys.2018.01710/full

Internet

https://www.frontiersin.org/article/10.3389/fphys.2018.01710/full

Similar Items